{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:59:39Z","timestamp":1790636379574,"version":"4.1.0"},"reference-count":42,"publisher":"American Association for Cancer Research (AACR)","issue":"18","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The chemokine receptor CXCR4 plays a central role in organ-specific homing and tumor spreading and is induced by hypoxia. B lymphocytes are exposed to low oxygen tensions during their development, but the influence of hypoxia on their physiology is poorly understood. Here, we show that hypoxia is associated with up-regulation of CXCR4 expression in human normal and malignant B cells, through both transcriptional and posttranslational mechanisms. However, a dichotomic functional response to CXCR4 triggering was observed: both peripheral B cells and lymphomas arising from mature B cells displayed increased responses to CXCR4 triggering under hypoxia, whereas germinal center (GC) B cells as well as GC-derived lymphomas showed CXCR4 receptor desensitization. This phenomenon was associated with differential modulation of key signal-transducing molecules, including mitogen-activated protein kinase phosphatase-1 and regulator of G protein signaling molecule-1. The unresponsiveness of GC-derived lymphomatous B cells to CXCR4 triggering under hypoxia may have implications for the development and pathogenesis of GC-derived lymphoid tumors. [Cancer Res 2007;67(18):8605\u201314]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-4722","type":"journal-article","created":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T13:53:12Z","timestamp":1190037192000},"page":"8605-8614","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Differential Regulation of Hypoxia-Induced CXCR4 Triggering during B-Cell Development and Lymphomagenesis"],"prefix":"10.1158","volume":"67","author":[{"given":"Erich","family":"Piovan","sequence":"first","affiliation":[{"name":"1Oncology Section, Department of Oncology and Surgical Sciences, University of Padova;"},{"name":"3Institute for Cancer Genetics and the Departments of Pathology and Genetics and Development, Columbia University, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tosello","sequence":"additional","affiliation":[{"name":"1Oncology Section, Department of Oncology and Surgical Sciences, University of Padova;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Indraccolo","sequence":"additional","affiliation":[{"name":"2Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Oncologico Veneto, Padua, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Masiero","sequence":"additional","affiliation":[{"name":"1Oncology Section, Department of Oncology and Surgical Sciences, University of Padova;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Persano","sequence":"additional","affiliation":[{"name":"1Oncology Section, Department of Oncology and Surgical Sciences, University of Padova;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[{"name":"2Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Oncologico Veneto, Padua, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Zamarchi","sequence":"additional","affiliation":[{"name":"2Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Oncologico Veneto, Padua, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"4Pathology Unit, San Raffaele Hospital Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Chieco-Bianchi","sequence":"additional","affiliation":[{"name":"1Oncology Section, Department of Oncology and Surgical Sciences, University of Padova;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dalla-Favera","sequence":"additional","affiliation":[{"name":"1Oncology Section, Department of Oncology and Surgical Sciences, University of Padova;"},{"name":"3Institute for Cancer Genetics and the Departments of Pathology and Genetics and Development, Columbia University, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Amadori","sequence":"additional","affiliation":[{"name":"1Oncology Section, Department of Oncology and Surgical Sciences, University of Padova;"},{"name":"2Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Oncologico Veneto, Padua, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,9,17]]},"reference":[{"key":"2022061623241051200_B1","doi-asserted-by":"crossref","unstructured":"Caldwell CC, Kojima H, Lukashev D, et al. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol\u20082001; 167: 6140\u20139.","DOI":"10.4049\/jimmunol.167.11.6140"},{"key":"2022061623241051200_B2","doi-asserted-by":"crossref","unstructured":"Maxwell PH, Dachs GU, Gleadle JM, et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A\u20081997; 94: 8104\u20139.","DOI":"10.1073\/pnas.94.15.8104"},{"key":"2022061623241051200_B3","doi-asserted-by":"crossref","unstructured":"Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev\u20081998; 8: 588\u201394.","DOI":"10.1016\/S0959-437X(98)80016-6"},{"key":"2022061623241051200_B4","doi-asserted-by":"crossref","unstructured":"Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med\u20082002; 8: S62\u20137.","DOI":"10.1016\/S1471-4914(02)02317-1"},{"key":"2022061623241051200_B5","doi-asserted-by":"crossref","unstructured":"Stewart M, Talks K, Leek R, et al. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology\u20082002; 40: 253\u201360.","DOI":"10.1046\/j.1365-2559.2002.01357.x"},{"key":"2022061623241051200_B6","doi-asserted-by":"crossref","unstructured":"Kojima H, Gu H, Nomura S, et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1\u03b1-deficient chimeric mice. Proc Natl Acad Sci U S A\u20082002; 99: 2170\u20134.","DOI":"10.1073\/pnas.052706699"},{"key":"2022061623241051200_B7","doi-asserted-by":"crossref","unstructured":"Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med\u20082001; 7: 345\u201350.","DOI":"10.1016\/S1471-4914(01)02090-1"},{"key":"2022061623241051200_B8","unstructured":"Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res\u20081996; 56: 4509\u201315."},{"key":"2022061623241051200_B9","unstructured":"Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res\u20081996; 56: 941\u20133."},{"key":"2022061623241051200_B10","doi-asserted-by":"crossref","unstructured":"Sundfor K, Lyng H, Rofstad EK. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer\u20081998; 78: 822\u20137.","DOI":"10.1038\/bjc.1998.586"},{"key":"2022061623241051200_B11","doi-asserted-by":"crossref","unstructured":"Schioppa T, Uranchimeg B, Saccani A, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med\u20082003; 198: 1391\u2013402.","DOI":"10.1084\/jem.20030267"},{"key":"2022061623241051200_B12","doi-asserted-by":"crossref","unstructured":"Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med\u20082004; 10: 858\u201364.","DOI":"10.1038\/nm1075"},{"key":"2022061623241051200_B13","doi-asserted-by":"crossref","unstructured":"Kryczek I, Lange A, Mottram P, et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res\u20082005; 65: 465\u201372.","DOI":"10.1158\/0008-5472.465.65.2"},{"key":"2022061623241051200_B14","doi-asserted-by":"crossref","unstructured":"Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol\u20082004; 14: 171\u20139.","DOI":"10.1016\/j.semcancer.2003.10.003"},{"key":"2022061623241051200_B15","doi-asserted-by":"crossref","unstructured":"Corcione A, Ottonello L, Tortolina G, et al. Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. J Natl Cancer Inst\u20082000; 92: 628\u201335.","DOI":"10.1093\/jnci\/92.8.628"},{"key":"2022061623241051200_B16","doi-asserted-by":"crossref","unstructured":"Allen CD, Ansel KM, Low C, et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol\u20082004; 5: 943\u201352.","DOI":"10.1038\/ni1100"},{"key":"2022061623241051200_B17","doi-asserted-by":"crossref","unstructured":"Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature\u20081988; 335: 256\u20139.","DOI":"10.1038\/335256a0"},{"key":"2022061623241051200_B18","doi-asserted-by":"crossref","unstructured":"Piovan E, Bonaldi L, Indraccolo S, et al. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation. Leukemia\u20082003; 17: 1643\u20139.","DOI":"10.1038\/sj.leu.2403005"},{"key":"2022061623241051200_B19","doi-asserted-by":"crossref","unstructured":"Razorenova OV, Ivanov AV, Budanov AV, Chumakov PM. Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1. Gene\u20082005; 350: 89\u201398.","DOI":"10.1016\/j.gene.2005.02.006"},{"key":"2022061623241051200_B20","unstructured":"Indraccolo S, Habeler W, Tisato V, et al. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Cancer Res\u20082002; 62: 6099\u2013107."},{"key":"2022061623241051200_B21","unstructured":"Custer RP, Bosma GC, Bosma MJ. Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am J Pathol\u20081985; 120: 464\u201377."},{"key":"2022061623241051200_B22","doi-asserted-by":"crossref","unstructured":"Rochford R, Mosier DE. Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J Virol\u20081995; 69: 150\u20135.","DOI":"10.1128\/jvi.69.1.150-155.1995"},{"key":"2022061623241051200_B23","doi-asserted-by":"crossref","unstructured":"Piovan E, Tosello V, Indraccolo S, et al. Chemokine receptor expression in EBV-associated lymphoproliferation in hu\/SCID mice: implications for CXCL12\/CXCR4 axis in lymphoma generation. Blood\u20082005; 105: 931\u20139.","DOI":"10.1182\/blood-2004-03-0799"},{"key":"2022061623241051200_B24","doi-asserted-by":"crossref","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A\u20081995; 92: 5510\u20134.","DOI":"10.1073\/pnas.92.12.5510"},{"key":"2022061623241051200_B25","doi-asserted-by":"crossref","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature\u20082000; 403: 503\u201311.","DOI":"10.1038\/35000501"},{"key":"2022061623241051200_B26","doi-asserted-by":"crossref","unstructured":"Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood\u20082005; 105: 659\u201369.","DOI":"10.1182\/blood-2004-07-2958"},{"key":"2022061623241051200_B27","doi-asserted-by":"crossref","unstructured":"Forster R, Kremmer E, Schubel A, et al. Intracellular and surface expression of the HIV-1 coreceptor CXCR4\/fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J Immunol\u20081998; 160: 1522\u201331.","DOI":"10.4049\/jimmunol.160.3.1522"},{"key":"2022061623241051200_B28","doi-asserted-by":"crossref","unstructured":"Rochford R, Mosier DE. Immunobiology of Epstein-Barr virus-associated lymphomas. Clin Immunol Immunopathol\u20081994; 71: 256\u20139.","DOI":"10.1006\/clin.1994.1082"},{"key":"2022061623241051200_B29","doi-asserted-by":"crossref","unstructured":"Bleul CC, Schultze JL, Springer TA. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med\u20081998; 187: 753\u201362.","DOI":"10.1084\/jem.187.5.753"},{"key":"2022061623241051200_B30","doi-asserted-by":"crossref","unstructured":"Parent CA, Blacklock BJ, Froehlich WM, Murphy DB, Devreotes PN. G protein signaling events are activated at the leading edge of chemotactic cells. Cell\u20081998; 95: 81\u201391.","DOI":"10.1016\/S0092-8674(00)81784-5"},{"key":"2022061623241051200_B31","doi-asserted-by":"crossref","unstructured":"Oh JW, Drabik K, Kutsch O, Choi C, Tousson A, Benveniste EN. CXC chemokine receptor 4 expression and function in human astroglioma cells. J Immunol\u20082001; 166: 2695\u2013704.","DOI":"10.4049\/jimmunol.166.4.2695"},{"key":"2022061623241051200_B32","doi-asserted-by":"crossref","unstructured":"Reif K, Cyster JG. RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J Immunol\u20082000; 164: 4720\u20139.","DOI":"10.4049\/jimmunol.164.9.4720"},{"key":"2022061623241051200_B33","doi-asserted-by":"crossref","unstructured":"Wain JH, Kirby JA, Ali S. Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by monocyte chemoattractant proteins-1, -2, -3 and -4. Clin Exp Immunol\u20082002; 127: 436\u201344.","DOI":"10.1046\/j.1365-2249.2002.01764.x"},{"key":"2022061623241051200_B34","doi-asserted-by":"crossref","unstructured":"Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia\u20082006; 20: 1915\u201324.","DOI":"10.1038\/sj.leu.2404357"},{"key":"2022061623241051200_B35","doi-asserted-by":"crossref","unstructured":"Denkert C, Schmitt WD, Berger S, et al. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma. Int J Cancer\u20082002; 102: 507\u201313.","DOI":"10.1002\/ijc.10746"},{"key":"2022061623241051200_B36","doi-asserted-by":"crossref","unstructured":"Moratz C, Kang VH, Druey KM, et al. Regulator of G protein signaling 1 (RGS1) markedly impairs Gi \u03b1 signaling responses of B lymphocytes. J Immunol\u20082000; 164: 1829\u201338.","DOI":"10.4049\/jimmunol.164.4.1829"},{"key":"2022061623241051200_B37","doi-asserted-by":"crossref","unstructured":"Shi GX, Harrison K, Wilson GL, Moratz C, Kehrl JH. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J Immunol\u20082002; 169: 2507\u201315.","DOI":"10.4049\/jimmunol.169.5.2507"},{"key":"2022061623241051200_B38","doi-asserted-by":"crossref","unstructured":"Moratz C, Hayman JR, Gu H, Kehrl JH. Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1\u2212\/\u2212 mice. Mol Cell Biol\u20082004; 24: 5767\u201375.","DOI":"10.1128\/MCB.24.13.5767-5775.2004"},{"key":"2022061623241051200_B39","doi-asserted-by":"crossref","unstructured":"Han JI, Huang NN, Kim DU, Kehrl JH. RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. J Leukoc Biol\u20082006; 79: 1357\u201368.","DOI":"10.1189\/jlb.1105693"},{"key":"2022061623241051200_B40","doi-asserted-by":"crossref","unstructured":"Chatterjee TK, Fisher RA. Cytoplasmic, nuclear, and Golgi localization of RGS proteins. Evidence for N-terminal and RGS domain sequences as intracellular targeting motifs. J Biol Chem\u20082000; 275: 24013\u201321.","DOI":"10.1074\/jbc.M002082200"},{"key":"2022061623241051200_B41","doi-asserted-by":"crossref","unstructured":"Turner L, Scotton C, Negus R, Balkwill F. Hypoxia inhibits macrophage migration. Eur J Immunol\u20081999; 29: 2280\u20137.","DOI":"10.1002\/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C"},{"key":"2022061623241051200_B42","doi-asserted-by":"crossref","unstructured":"Makino Y, Nakamura H, Ikeda E, et al. Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J Immunol\u20082003; 171: 6534\u201340.","DOI":"10.4049\/jimmunol.171.12.6534"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/18\/8605\/2572921\/8605.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/18\/8605\/2572921\/8605.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T00:48:38Z","timestamp":1684025318000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/18\/8605\/533454\/Differential-Regulation-of-Hypoxia-Induced-CXCR4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,15]]},"references-count":42,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2007,9,17]]},"published-print":{"date-parts":[[2007,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-4722","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496082","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496082.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22368710","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368698","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368701","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368713","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368716","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368707","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368710.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368713.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368716.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368707.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368698.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22368701.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,15]]}}}